Adam L - Search Results

1

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. Santarpia L, et al. Among authors: adam l. Endocr Relat Cancer. 2013 Oct 14;20(6):809-23. doi: 10.1530/ERC-13-0357. Print 2013 Dec. Endocr Relat Cancer. 2013. PMID: 24127332

2

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.

Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C. Adam L, et al. Clin Cancer Res. 2009 Aug 15;15(16):5060-72. doi: 10.1158/1078-0432.CCR-08-2245. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671845 Free PMC article.

3

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.

Yang Z, Bagheri-Yarmand R, Wang RA, Adam L, Papadimitrakopoulou VV, Clayman GL, El-Naggar A, Lotan R, Barnes CJ, Hong WK, Kumar R. Yang Z, et al. Among authors: adam l. Clin Cancer Res. 2004 Jan 15;10(2):658-67. doi: 10.1158/1078-0432.ccr-0382-03. Clin Cancer Res. 2004. PMID: 14760089

4

Apoptosis in mammary gland and cancer.

Kumar R, Vadlamudi RK, Adam L. Kumar R, et al. Among authors: adam l. Endocr Relat Cancer. 2000 Dec;7(4):257-69. doi: 10.1677/erc.0.0070257. Endocr Relat Cancer. 2000. PMID: 11174847 Review.

5

Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.

Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP. Black PC, et al. Among authors: adam l. Clin Cancer Res. 2008 Mar 1;14(5):1478-86. doi: 10.1158/1078-0432.CCR-07-1593. Clin Cancer Res. 2008. PMID: 18316572

6

Plasma microRNA profiles for bladder cancer detection.

Adam L, Wszolek MF, Liu CG, Jing W, Diao L, Zien A, Zhang JD, Jackson D, Dinney CP. Adam L, et al. Urol Oncol. 2013 Nov;31(8):1701-8. doi: 10.1016/j.urolonc.2012.06.010. Epub 2012 Aug 3. Urol Oncol. 2013. PMID: 22863868 Free PMC article.

7

Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.

Vadlamudi R, Adam L, Tseng B, Costa L, Kumar R. Vadlamudi R, et al. Among authors: adam l. Cancer Res. 1999 Jun 15;59(12):2843-6. Cancer Res. 1999. PMID: 10383144

8

Heregulin regulation of autocrine motility factor expression in human tumor cells.

Talukder AH, Adam L, Raz A, Kumar R. Talukder AH, et al. Among authors: adam l. Cancer Res. 2000 Jan 15;60(2):474-80. Cancer Res. 2000. PMID: 10667603

9

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Blehm KN, et al. Among authors: adam l. Clin Cancer Res. 2006 Aug 1;12(15):4671-7. doi: 10.1158/1078-0432.CCR-06-0407. Clin Cancer Res. 2006. PMID: 16899617

10

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

Shrader M, Pino MS, Lashinger L, Bar-Eli M, Adam L, Dinney CP, McConkey DJ. Shrader M, et al. Among authors: adam l. Cancer Res. 2007 Feb 15;67(4):1430-5. doi: 10.1158/0008-5472.CAN-06-1224. Cancer Res. 2007. PMID: 17308080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters